Insilico Medicine and Liquid AI launch 2.6B parameter model
Insilico Medicine and Liquid AI collaborate to create LFM2-2.6B-MMAI, a lightweight scientific foundation model for pharmaceutical research, achieving industry-leading performance in multiple drug discovery benchmarks.
Insilico Medicine and Liquid AI partner for drug discovery
Insilico Medicine and Liquid AI partner to create lightweight scientific foundation models for drug discovery, launching LFM2-2.6B-MMAI (v0.2.1) for pharmaceutical research.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.